Nutrineal Solution for Peritoneal Dialysis 4 with 1.1% amino acids * Pharmacy Only: Prescription
Company:
Baxter Holding B.V.Status:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 02 April 2019
File name
ie-spc-2019-03-nutrineal-2299016001-mah-c_1554194894.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 27 December 2017
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.8 - Undesirable effects
- Change to section 6.4 - Special precautions for storage
- Change to section 10 - Date of revision of the text
Free text change information supplied by the pharmaceutical company
Section 2 - change all qualitative and quantitative compositions and change Lysine chlorhydrate to Lysine Hydrochloride.
Section 4.8 - addition reporting of suspected adverse reactions statement.
Section 6.4 - change in storage instructions - Keep in outer carton in order to protect from light.
Section 4.8 - addition reporting of suspected adverse reactions statement.
Section 6.4 - change in storage instructions - Keep in outer carton in order to protect from light.
Updated on 27 December 2017
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.8 - Undesirable effects
- Change to section 6.4 - Special precautions for storage
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Section 2 - change all qualitative and quantitative compositions and change Lysine chlorhydrate to Lysine Hydrochloride.
Section 4.8 - addition reporting of suspected adverse reactions statement.
Section 6.4 - change in storage instructions - Keep in outer carton in order to protect from light.
Section 4.8 - addition reporting of suspected adverse reactions statement.
Section 6.4 - change in storage instructions - Keep in outer carton in order to protect from light.
Updated on 27 December 2017
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 01 September 2016
Reasons for updating
- New SPC for medicines.ie
Free text change information supplied by the pharmaceutical company
None provided
Updated on 01 September 2016
Reasons for updating
- New SPC for medicines.ie
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
None provided